Succefull global regulatory filing and approvals of NDA, sNDA, EU MAA, MRP and Japanese MHW in CNS, Cardiovascular, Oncology, Anti-infection, Hypertension, and other therapeutic areas.
Extensive management experience in pharmaceutical development, in-licensing evaluations, global medical affairs, and global marketing with Phase 3B studies, post-marketing Phase 4 studies , labeling studies, publications, professional education, medical information and all activities in life cycle management (LCM).
Users being followed by Otsuka Pharmaceutical Companies (U.S.)
We’ve updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
